Measuring brain perfusion with intravoxel incoherent motion (IVIM): Initial clinical experience

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 3, 2014, Pages 624-632

  Federau, Christian ^a   O'Brien, Kieran ^b   Meuli, Reto ^a   Hagmann, Patric ^a   Maeder, Philippe ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

brain; diffusion; intravoxel incoherent motion (IVIM); perfusion

Indexed keywords

CONTRAST MEDIUM;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; DIAGNOSTIC USE; DIFFUSION WEIGHTED IMAGING; ENCEPHALITIS; EPIDEMIOLOGY; FEASIBILITY STUDY; FEMALE; GLIOMA; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PERFUSION; PROCEDURES; SENSITIVITY AND SPECIFICITY; STROKE; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; ENCEPHALITIS; FEASIBILITY STUDIES; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PERFUSION; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STROKE; YOUNG ADULT;

EID: 84894261868     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24195     Document Type: Article

References (51)

1. Wechsler LR,. Imaging evaluation of acute ischemic stroke. Stroke 2011; 42: S12-51.
2. Furlan AJ, Eyding D, Albers GW, et al. Dose escalation of desmoteplase for acute ischemic stroke: evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006; 37: 1227-1231.
3. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial: a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73.
4. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT: a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009; 8: 141-150.
5. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508-517.
6. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial: a placebo-controlled randomised trial. Lancet Neurol 2008; 7: 299-309.
7. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24: 1989-1998.
8. Law M, Young RJ, Babb JS, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008; 247: 490-498.
9. Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168: 497-505.
10. Stejskal EO, Tanner JE,. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965; 42: 288-292.
11. Le Bihan D, Turner R,. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 1992; 27: 171-178.
12. Ahn CB, Lee SY, Nalcioglu O, et al. The effects of random directional distributed flow in nuclear magnetic resonance imaging. Med Phys 1987; 14: 43-48.
13. Henkelman RM, Neil JJ, Xiang QS,. A quantitative interpretation of IVIM measurements of vascular perfusion in the rat brain. Magn Reson Med 1994; 32: 464-469.
14. Kennan RP, Gao JH, Zhong J, et al. A general model of microcirculatory blood flow effects in gradient sensitized MRI. Med Phys 1994; 21: 539-545.
15. Conturo TE, McKinstry RC, Aronovitz JA, et al. Diffusion MRI: precision, accuracy and flow effects. NMR Biomed 1995; 8: 307-332.
16. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008; 249: 891-899.
17. Guiu B, Petit JM, Capitan V, et al. Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. Radiology 2012; 265: 96-103.
18. Thoeny HC, Binser T, Roth B, et al. Noninvasive assessment of acute ureteral obstruction with diffusion-weighted MR imaging: a prospective study. Radiology 2009; 252: 721-728.
19. Lemke A, Laun FB, Klauss M, et al. Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple b-values: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Invest Radiol 2009; 44: 769-775.
20. Sigmund EE, Cho GY, Kim S, et al. Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med 2011; 65: 1437-1447.
21. Riches SF, Hawtin K, Charles-Edwards EM, et al. Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients. NMR Biomed 2009; 22: 318-325.
22. Sumi M, Van Cauteren M, Sumi T, Obara M, Ichikawa Y, Nakamura T,. Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology 2012; 263: 770-777.
23. Sumi M, Nakamura T,. Head and neck tumors: assessment of perfusion-related parameters and diffusion coefficients based on the intravoxel incoherent motion model. AJNR Am J Neuroradiol 2013; 34: 410-416.
24. Turner R, Le Bihan D, Maier J, et al. Echo-planar imaging of intravoxel incoherent motion. Radiology 1990; 177: 407-414.
25. Neil JJ, Bosch CS, Ackerman JJ,. An evaluation of the sensitivity of the intravoxel incoherent motion (IVIM) method of blood flow measurement to changes in cerebral blood flow. Magn Reson Med 1994; 32: 60-65.
26. Chenevert TL, Pipe JG, Williams DM, et al. Quantitative measurement of tissue perfusion and diffusion in vivo. Magn Reson Med 1991; 17: 197-212.
27. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: 401-407.
28. Le Bihan D, Moonen CT, van Zijl PC, et al. Measuring random microscopic motion of water in tissues with MR imaging: a cat brain study. J Comput Assist Tomogr 1991; 15: 19-25.
29. Wirestam R, Brockstedt S, Lindgren A, et al. The perfusion fraction in volunteers and in patients with ischaemic stroke. Acta Radiol 1997; 38: 961-964.
30. Federau C, Maeder P, O'Brien K, et al. Quantitative measurement of brain perfusion with intravoxel incoherent motion MR imaging. Radiology 2012; 265: 874-881.
31. Seber GA, Wild CJ,. Nonlinear regression. Hoboken, NJ: Wiley-Interscience; 2003.
32. Le Bihan D, Turner R, MacFall JR,. Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: applicatons to molecular diffusion imaging. Magn Reson Med 1989; 10: 324-337.
33. Paulson ES, Schmainda KM,. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008; 249: 601-613.
34. Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14: 249-265.
35. Huber P,. Cerebral angiography. 2nd ed. New York: Thieme; 1982.
36. Cronqvist S,. Angiography and cerebral blood flow in malignant glioma. Acta Radiol Ther Phys Biol 1969; 8: 78-85.
37. Scatliff JH, Radcliffe WB, Pittman HH, et al. Vascular structure of glioblastomas. Am J Roentgenol Radium Ther Nuclear Med 1969; 105: 795-805.
38. Jain RK, di Tomaso E, Duda DG, et al. Angiogenesis in brain tumours. Nat Rev Neurosci 2007; 8: 610-622.
39. Baish JW, Jain RK,. Fractals and cancer. Cancer Res 2000; 60: 3683-3688.
40. Danchaivijitr N, Waldman AD, Tozer DJ, et al. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 2008; 247: 170-178.
41. Gore JC, Majumdar S,. Measurement of tissue blood flow using intravascular relaxation agents and magnetic resonance imaging. Magn Reson Med 1990; 14: 242-248.
42. Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 1990; 176: 211-220.
43. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988; 6: 164-174.
44. Ito H, Kanno I, Fukuda H,. Human cerebral circulation: positron emission tomography studies. Ann Nucl Med 2005; 19: 65-74.
45. Majumdar S, Zoghbi SS, Gore JC,. Regional differences in rat brain displayed by fast MRI with superparamagnetic contrast agents. Magn Reson Imaging 1988; 6: 611-615.
46. Fisel CR, Ackerman JL, Buxton RB, et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991; 17: 336-347.
47. Calamante F, Gadian DG, Connelly A,. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 2002; 33: 1146-1151.
48. Knutsson L, Stahlberg F, Wirestam R,. Absolute quantification of perfusion using dynamic susceptibility contrast MRI: pitfalls and possibilities. MAGMA 2010; 23: 1-21.
49. Petersen ET, Zimine I, Ho YC, et al. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol 2006; 79: 688-701.
50. Lemke A, Stieltjes B, Schad LR, Laun FB,. Toward an optimal distribution of b values for intravoxel incoherent motion imaging. Magn Reson Imaging 2011; 29: 766-776.
51. King MD, van Bruggen N, Busza AL, Houseman J, Williams SR, Gadian DG,. Perfusion and diffusion MR imaging. Magn Reson Med 1992; 24: 288-301.